Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer

The long arm of chromosome 8 is one of the most common regions of amplification in cancers of several organs, especially carcinomas of the breast and prostate. TRPS1, MYC and EIF3S3 genes are located in one of the minimal regions of amplification, 8q23–q24, and have been suggested to be the target genes of the amplification. Here, our goal was to study copy number and expression of the three genes in order to investigate the significance of the genes in breast and prostate cancer. By using fluorescence in situ hybridisation (FISH), we first found that TRPS1 and EIF3S3 were amplified together in about one-third of hormone-refractory prostate carcinomas. Next, we analysed the mRNA expression of the three genes by real-time quantitative RT–PCR and the gene copy number by FISH in six breast and five prostate cancer cell lines. Breast cancer cell line, SK-Br-3, which contained the highest copy number of all three genes, showed overexpression of only EIF3S3. Finally, the expression levels of TRPS1, EIF3S3 and MYC were measured in freshly frozen clinical samples of benign prostate hyperplasia (BPH), as well as untreated and hormone-refractory prostate carcinoma. The TRPS1 and MYC expression levels were similar in all prostate tumour groups, whereas EIF3S3 expression was higher (P=0.029) in prostate carcinomas compared to BPH. The data suggest that the expression of EIF3S3 is increased in prostate cancer, and that one of the mechanisms underlying the overexpression is the amplification of the gene.

[1]  J Piper,et al.  Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J Isola,et al.  Molecular cytogenetics of primary breast cancer by CGH , 1998, Genes, chromosomes & cancer.

[3]  R. Shivdasani,et al.  Transcriptional repression and developmental functions of the atypical vertebrate GATA protein TRPS1 , 2001, The EMBO journal.

[4]  T. Tammela,et al.  Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer. , 2002, The American journal of pathology.

[5]  M. Loda,et al.  Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Isola,et al.  Amplification of c-myc Oncogene by Chromogenic and Fluorescence In Situ Hybridization in Archival Breast Cancer Tissue Array Samples , 2001, Laboratory Investigation.

[7]  A. De Benedetti,et al.  Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Bostwick,et al.  Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. , 1997, Cancer research.

[9]  R L Vessella,et al.  Advances in Brief Amplification and Overexpression of Androgen Receptor Gene in Hormone-Refractory Prostate Cancer 1 , 2001 .

[10]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[11]  T. Visakorpi,et al.  Mapping the amplification of EIF3S3 in breast and prostate cancer , 2000, Genes, chromosomes & cancer.

[12]  A. De Benedetti,et al.  Overexpression of the proto‐oncogene/translation factor 4E in breast‐carcinoma cell lines , 1996, International journal of cancer.

[13]  S. Hilsenbeck,et al.  Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. , 1995, The American journal of pathology.

[14]  B. Eussen,et al.  Characterization of a zinc-finger protein and its association with apoptosis in prostate cancer cells. , 2000, Journal of the National Cancer Institute.

[15]  T. Visakorpi,et al.  Genetic alterations in hormone-refractory recurrent prostate carcinomas. , 1998, The American journal of pathology.

[16]  O. Kallioniemi,et al.  Genome screening by comparative genomic hybridization. , 1997, Trends in genetics : TIG.

[17]  A. Brinkmann,et al.  Structure and function of GC79/TRPS1, a novel androgen-repressible apoptosis gene , 2002, Apoptosis.

[18]  T. Visakorpi,et al.  Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. , 1995, Cancer research.

[19]  I. Bièche,et al.  Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. , 1999, Cancer research.

[20]  J W Hershey,et al.  Structure of cDNAs Encoding Human Eukaryotic Initiation Factor 3 Subunits , 1997, The Journal of Biological Chemistry.

[21]  T. Visakorpi,et al.  Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer. , 2001, The American journal of pathology.

[22]  K. Porkka,et al.  Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. , 1999, The American journal of pathology.

[23]  H. Tanke,et al.  Identification of Genetic Markers for Prostatic Cancer Progression , 2000, Laboratory Investigation.

[24]  T. Visakorpi,et al.  Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization. , 1994, Cytometry.

[25]  N. Niikawa,et al.  Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III. , 2001, American journal of human genetics.

[26]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[27]  R. Hennekam,et al.  Mutations in a new gene, encoding a zinc-finger protein, cause tricho-rhino-phalangeal syndrome type I , 2000, Nature Genetics.

[28]  P. Carroll,et al.  Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. , 1996, Cancer research.

[29]  T. Fukuchi-Shimogori,et al.  Malignant transformation by overproduction of translation initiation factor eIF4G. , 1997, Cancer research.